Literature DB >> 26347122

[Biomarkers for prognosis of response to anti-TNF therapy of rheumatoid arthritis: Where do we stand?].

B Stuhlmüller1, K Skriner2, T Häupl2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26347122     DOI： 10.1007/s00393-014-1543-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  58 in total

1.  Combined tumour necrosis factor-alpha and tumour necrosis factor receptor genotypes could predict rheumatoid arthritis patients' response to anti-TNF-alpha therapy and explain controversies of studies based on a single polymorphism.

Authors:  A Chatzikyriakidou; I Georgiou; P V Voulgari; A I Venetsanopoulou; A A Drosos
Journal:  Rheumatology (Oxford)       Date:  2007-04-04       Impact factor: 7.580

2.  Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.

Authors:  Catherine Potter; Heather J Cordell; Anne Barton; Ann K Daly; Kimme L Hyrich; Derek A Mann; Ann W Morgan; Anthony G Wilson; John D Isaacs
Journal:  Ann Rheum Dis       Date:  2010-05-06       Impact factor: 19.103

3.  The use of an interferon-gamma release assay as a biomarker of response to anti-TNF-alpha treatment.

Authors:  Fabio Cacciapaglia; Francesca Buzzulini; Luisa Arcarese; Elisabetta Ferraro; Antonella Afeltra
Journal:  Drug Dev Res       Date:  2014-11       Impact factor: 4.360

4.  Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Authors:  K L Hyrich; K D Watson; A J Silman; D P M Symmons
Journal:  Rheumatology (Oxford)       Date:  2006-05-16       Impact factor: 7.580

5.  From transcriptome to cytome: integrating cytometric profiling, multivariate cluster, and prediction analyses for a phenotypical classification of inflammatory diseases.

Authors:  Marta Steinbrich-Zöllner; Joachim R Grün; Toralf Kaiser; Robert Biesen; Katharina Raba; Peihua Wu; Andreas Thiel; Martin Rudwaleit; Joachim Sieper; Gerd-Rüdiger Burmester; Andreas Radbruch; Andreas Grützkau
Journal:  Cytometry A       Date:  2008-04       Impact factor: 4.355

6.  Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patients.

Authors:  Kenzie D MacIsaac; Richard Baumgartner; Jia Kang; Andrey Loboda; Charles Peterfy; Julie DiCarlo; Jonathan Riek; Chan Beals
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

7.  Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis.

Authors:  Wolfgang Hueber; Beren H Tomooka; Franak Batliwalla; Wentian Li; Paul A Monach; Robert J Tibshirani; Ronald F Van Vollenhoven; Jon Lampa; Kazuyoshi Saito; Yoshiya Tanaka; Mark C Genovese; Lars Klareskog; Peter K Gregersen; William H Robinson
Journal:  Arthritis Res Ther       Date:  2009-05-21       Impact factor: 5.156

8.  Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis.

Authors:  Luis Chara; Ana Sánchez-Atrio; Ana Pérez; Eduardo Cuende; Fernando Albarrán; Ana Turrión; Julio Chevarria; Miguel A Sánchez; Jorge Monserrat; Antonio de la Hera; Alfredo Prieto; Ignacio Sanz; David Diaz; Melchor Alvarez-Mon
Journal:  Arthritis Res Ther       Date:  2012-07-27       Impact factor: 5.156

9.  Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanercept.

Authors:  Dirk Koczan; Susanne Drynda; Michael Hecker; Andreas Drynda; Reinhard Guthke; Joern Kekow; Hans-Juergen Thiesen
Journal:  Arthritis Res Ther       Date:  2008-05-02       Impact factor: 5.156

10.  Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome.

Authors:  Jacob Sode; Ulla Vogel; Steffen Bank; Paal Skytt Andersen; Marianne Kragh Thomsen; Merete Lund Hetland; Henning Locht; Niels H H Heegaard; Vibeke Andersen
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240
View more
  1 in total

1.  ATRPred: A machine learning based tool for clinical decision making of anti-TNF treatment in rheumatoid arthritis patients.

Authors:  Bodhayan Prasad; Cathy McGeough; Amanda Eakin; Tan Ahmed; Dawn Small; Philip Gardiner; Adrian Pendleton; Gary Wright; Anthony J Bjourson; David S Gibson; Priyank Shukla
Journal:  PLoS Comput Biol       Date:  2022-07-05       Impact factor: 4.779
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.